XML 95 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation - Restricted Stock and Performance-based Restrcited Stock Activity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2018
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 31,324,000 $ 15,324,000 $ 10,454,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Weighted Average Remaining Recognition Period (Years)     3 years 2 months 12 days      
Market-based Restricted Stock Units (MSU)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 4,500,000      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted (in shares) 1,000,000 1,300,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Expected term (in years) 3 years 1 month 6 days          
Dividend yield 0.00%          
Restricted Stock [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested (in shares)     1,053,524 932,138 906,341  
Granted (in shares)     597,381 722,873 505,440  
Vested (in shares)     (410,670) (567,087) (455,893)  
Forfeited (in shares)     (70,626) (34,400) (23,750)  
Nonvested (in shares)     1,169,609 1,053,524 932,138 906,341
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 21.60 $ 11.36 $ 14.09  
Granted (in dollars per share)     45.83 29.85 8.51  
Vested (in dollars per share)     20.54 15.70 13.53  
Forfeited (in dollars per share)     26.79 14.88 13.19  
Nonvested (in dollars per share)     $ 34.03 $ 21.60 $ 11.36 $ 14.09
Weighted Average Remaining Recognition Period (Years)     1 year 8 months 23 days 1 year 8 months 23 days 1 year 7 months 28 days 1 year 7 months 13 days
Aggregate intrinsic value, nonvested     $ 38,994,764 $ 32,016,594 $ 10,141,661 $ 8,465,225
Performance Based Restricted Stock Units (PRSUs)            
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]            
Allocated share-based compensation expense     $ 4,600,000 $ 2,300,000 $ 1,500,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested (in shares)     353,824 342,775 596,724  
Granted (in shares)     194,000 165,500 155,000  
Vested (in shares)     (151,199) (148,211) (110,659)  
Forfeited (in shares)     (7,250) (6,240) (298,290)  
Nonvested (in shares)     389,375 353,824 342,775 596,724
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]            
Nonvested (in dollars per share)     $ 22.69 $ 12.38 $ 13.95  
Granted (in dollars per share)     48.65 36.27 7.36  
Vested (in dollars per share)     19.44 14.24 16.68  
Forfeited (in dollars per share)     40.33 17.23 11.32  
Nonvested (in dollars per share)     $ 36.56 $ 22.69 $ 12.38 $ 13.95
Weighted Average Remaining Recognition Period (Years)     1 year 10 months 6 days 1 year 8 months 26 days 1 year 7 months 6 days 1 year 10 months 17 days
Aggregate intrinsic value, nonvested     $ 12,981,763 $ 10,752,711 $ 3,729,392 $ 5,573,402